Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin.

Damiano L, Stewart KM, Cohet N, Mouw JK, Lakins JN, Debnath J, Reisman D, Nickerson JA, Imbalzano AN, Weaver VM.

Oncogene. 2014 May 8;33(19):2441-53. doi: 10.1038/onc.2013.220. Epub 2013 Jun 17.

2.

CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells.

Barakat DJ, Zhang J, Barberi T, Denmeade SR, Friedman AD, Paz-Priel I.

Oncogene. 2015 Nov 26;34(48):5912-22. doi: 10.1038/onc.2015.41. Epub 2015 Mar 16.

3.

Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene.

Wang F, Zhang R, Beischlag TV, Muchardt C, Yaniv M, Hankinson O.

J Biol Chem. 2004 Nov 5;279(45):46733-41. Epub 2004 Sep 3.

4.

ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.

Haenssen KK, Caldwell SA, Shahriari KS, Jackson SR, Whelan KA, Klein-Szanto AJ, Reginato MJ.

J Cell Sci. 2010 Apr 15;123(Pt 8):1373-82. doi: 10.1242/jcs.050906. Epub 2010 Mar 23.

5.

ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions.

Spangenberg C, Lausch EU, Trost TM, Prawitt D, May A, Keppler R, Fees SA, Reutzel D, Bell C, Schmitt S, Schiffer IB, Weber A, Brenner W, Hermes M, Sahin U, Türeci O, Koelbl H, Hengstler JG, Zabel BU.

Cancer Res. 2006 Apr 1;66(7):3715-25.

7.

Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration.

Qin L, Chen X, Wu Y, Feng Z, He T, Wang L, Liao L, Xu J.

Cancer Res. 2011 Mar 1;71(5):1742-51. doi: 10.1158/0008-5472.CAN-10-3453. Epub 2011 Feb 22.

8.

ZEB2-Sp1 cooperation induces invasion by upregulating cadherin-11 and integrin α5 expression.

Nam EH, Lee Y, Zhao XF, Park YK, Lee JW, Kim S.

Carcinogenesis. 2014 Feb;35(2):302-14. doi: 10.1093/carcin/bgt340. Epub 2013 Oct 15.

PMID:
24130169
9.

MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers.

Sakurai K, Furukawa C, Haraguchi T, Inada K, Shiogama K, Tagawa T, Fujita S, Ueno Y, Ogata A, Ito M, Tsutsumi Y, Iba H.

Cancer Res. 2011 Mar 1;71(5):1680-9. doi: 10.1158/0008-5472.CAN-10-2345. Epub 2010 Dec 28.

10.

MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells.

Alam M, Ahmad R, Rajabi H, Kharbanda A, Kufe D.

J Biol Chem. 2013 Oct 25;288(43):30892-903. doi: 10.1074/jbc.M113.477158. Epub 2013 Sep 16.

11.

Modulation of Brahma expression by the mitogen-activated protein kinase/extracellular signal regulated kinase pathway is associated with changes in melanoma proliferation.

Mehrotra A, Saladi SV, Trivedi AR, Aras S, Qi H, Jayanthy A, Setaluri V, de la Serna IL.

Arch Biochem Biophys. 2014 Dec 1;563:125-35. doi: 10.1016/j.abb.2014.07.004. Epub 2014 Jul 12.

12.

ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.

Nam EH, Lee Y, Park YK, Lee JW, Kim S.

Carcinogenesis. 2012 Mar;33(3):563-71. doi: 10.1093/carcin/bgs005. Epub 2012 Jan 6.

PMID:
22227038
13.

Integrin subunits alpha5 and alpha6 regulate cell cycle by modulating the chk1 and Rb/E2F pathways to affect breast cancer metastasis.

Wang Y, Shenouda S, Baranwal S, Rathinam R, Jain P, Bao L, Hazari S, Dash S, Alahari SK.

Mol Cancer. 2011 Jul 13;10:84. doi: 10.1186/1476-4598-10-84.

14.

A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.

Morel AP, Ginestier C, Pommier RM, Cabaud O, Ruiz E, Wicinski J, Devouassoux-Shisheboran M, Combaret V, Finetti P, Chassot C, Pinatel C, Fauvet F, Saintigny P, Thomas E, Moyret-Lalle C, Lachuer J, Despras E, Jauffret JL, Bertucci F, Guitton J, Wierinckx A, Wang Q, Radosevic-Robin N, Penault-Llorca F, Cox DG, Hollande F, Ansieau S, Caramel J, Birnbaum D, Vigneron AM, Tissier A, Charafe-Jauffret E, Puisieux A.

Nat Med. 2017 May;23(5):568-578. doi: 10.1038/nm.4323. Epub 2017 Apr 10.

PMID:
28394329
15.
16.

SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation.

Banine F, Bartlett C, Gunawardena R, Muchardt C, Yaniv M, Knudsen ES, Weissman BE, Sherman LS.

Cancer Res. 2005 May 1;65(9):3542-7.

17.

Mammalian chromatin remodeling complex SWI/SNF is essential for enhanced expression of the albumin gene during liver development.

Inayoshi Y, Miyake K, Machida Y, Kaneoka H, Terajima M, Dohda T, Takahashi M, Iijima S.

J Biochem. 2006 Feb;139(2):177-88.

PMID:
16452305
18.

A functional N-terminal domain in C/EBPβ-LAP* is required for interacting with SWI/SNF and to repress Ric-8B gene transcription in osteoblasts.

Aguilar R, Grandy R, Meza D, Sepulveda H, Pihan P, van Wijnen AJ, Lian JB, Stein GS, Stein JL, Montecino M.

J Cell Physiol. 2014 Oct;229(10):1521-8. doi: 10.1002/jcp.24595.

19.

PTHrP increases transcriptional activity of the integrin subunit alpha5.

Anderson JA, Grabowska AM, Watson SA.

Br J Cancer. 2007 May 7;96(9):1394-403. Epub 2007 Apr 3.

Supplemental Content

Support Center